Clinical Trial Update: Ultralow Dose PET Imaging of 18F-FDG Uptake [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ultralow-dose PET imaging of 18F-FDG uptake in healthy volunteers and cancer patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)

Snippet

Sponsor: Akiva Mintz | Conditions: Healthy Volunteer, Cancer | Phase 2 | Status: RECRUITING